Protein Variants | Comment | Organism |
---|---|---|
additional information | development and evaluation of a high-throughput affinity-based screening technology, ATLAS, for soluble proteins, e.g. p38 MAP kinase, effects of p38 MAP kinase inhibitors, overview | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2-(4-chlorphenyl)-4-(4-fluorophenyl)-5-pyridin-4-yl-1,2-dihydropyrazol-3-one | - |
Homo sapiens | |
additional information | effects of inhibitors on ATLAS technology assay, overview | Homo sapiens | |
PD169316 | - |
Homo sapiens | |
SB202190 | - |
Homo sapiens | |
SB203580 | - |
Homo sapiens | |
SB203580-iodo | - |
Homo sapiens | |
SB203580-sulfone | - |
Homo sapiens | |
SB220025 | - |
Homo sapiens | |
SC68376 | - |
Homo sapiens | |
SKF86002 | - |
Homo sapiens |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mg2+ | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q16539 | isozyme p38 MAPKalpha | - |
Purification (Comment) | Organism |
---|---|
His-tagged p38 MAP kinase | Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
commercial preparation | nonactivated p38 MAP kinase | Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
p38 MAP kinase | - |
Homo sapiens |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
25 | - |
assay at | Homo sapiens |
Temperature Stability Minimum [°C] | Temperature Stability Maximum [°C] | Comment | Organism |
---|---|---|---|
20 | 50 | cooperative thermal unfolding profile of p38 MAP kinase, overview | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.2 | - |
assay at | Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.00003 | 0.0006 | pH 7.2, 25°C | Homo sapiens | SB203580 | |
0.001 | - |
pH 7.2, 25°C | Homo sapiens | SKF86002 | |
0.002 | 0.005 | pH 7.2, 25°C | Homo sapiens | SC68376 |